Related Experiment Video
Updated: Jul 16, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Affinity-based ranking of ligands for DPP-4 from mixtures
Gregory C Adam1, Juncai Meng, John Athanasopoulos
1Department of Target Validation, Merck & Co., Inc., PO Box 2000, Rahway, NJ 07065, USA. gregory_adam@merck.com
We present a novel affinity selection method to rank ligand mixtures for drug discovery. This approach efficiently identifies potent inhibitors for enzymes like dipeptidyl peptidase IV.
Area of Science:
- Biochemistry and Drug Discovery
- Chemical Biology
- Enzymology
Background:
- High throughput screening (HTS) is a traditional method for identifying drug lead compounds.
- --Omics technologies are generating a vast number of novel protein targets for drug development.
- Affinity-based selection strategies offer a complementary approach to HTS for target-based drug discovery.
Purpose of the Study:
- To describe a novel method for ranking mixtures of ligands based on affinity selection.
- To apply this method for the efficient ranking of enzyme inhibitors.
- To demonstrate the utility of affinity selection for identifying lead compounds against emerging protein targets.
Main Methods:
- Development of an affinity selection-based methodology for ranking ligand mixtures.
- Application of the method to a set of dipeptidyl peptidase IV (DPP-IV) inhibitors.
- Comparative analysis of affinity selection rankings against traditional screening data.
Main Results:
- The described affinity selection method successfully ranked mixtures of ligands.
- The method provided an efficient means to order dipeptidyl peptidase IV inhibitors by affinity.
- This approach complements HTS by enabling rapid assessment of compound libraries.
Conclusions:
- Affinity-based selection is a valuable tool for accelerating lead compound discovery.
- The developed method offers a rapid and effective way to rank potential inhibitors.
- This strategy is applicable to a wide range of protein targets identified through --omics research.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Affinity Chromatography
Complexometric Titration: Ligands
The Equilibrium Binding Constant and Binding Strength
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

